vs
COLLEGIUM PHARMACEUTICAL, INC（COLL）与PREFORMED LINE PRODUCTS CO（PLPC）财务数据对比。点击上方公司名可切换其他公司
COLLEGIUM PHARMACEUTICAL, INC的季度营收约是PREFORMED LINE PRODUCTS CO的1.2倍（$205.4M vs $173.1M），COLLEGIUM PHARMACEUTICAL, INC净利率更高（8.3% vs 4.9%，领先3.4%），COLLEGIUM PHARMACEUTICAL, INC同比增速更快（12.9% vs 3.6%），COLLEGIUM PHARMACEUTICAL, INC自由现金流更多（$122.4M vs $11.8M），过去两年COLLEGIUM PHARMACEUTICAL, INC的营收复合增速更高（19.1% vs 10.8%）
Collegium制药是一家专科制药企业，专注于研发和商业化具备滥用威慑特性的创新疼痛管理疗法，主要面向美国市场，推出适用于慢性疼痛患者的缓释镇痛产品，服务覆盖基层及专科医疗领域的医护人员。
预成型线路产品公司（PLPC）研发、生产和销售适用于输配电、通信及可再生能源基建领域的工程硬件组件，服务全球多地的公用事业、网络运营商及工业客户，提供可提升网络可靠性与运营效率的解决方案。
COLL vs PLPC — 直观对比
营收规模更大
COLL
是对方的1.2倍
$173.1M
营收增速更快
COLL
高出9.3%
3.6%
净利率更高
COLL
高出3.4%
4.9%
自由现金流更多
COLL
多$110.6M
$11.8M
两年增速更快
COLL
近两年复合增速
10.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $205.4M | $173.1M |
| 净利润 | $17.0M | $8.4M |
| 毛利率 | 62.5% | 29.8% |
| 营业利润率 | 29.6% | 6.8% |
| 净利率 | 8.3% | 4.9% |
| 营收同比 | 12.9% | 3.6% |
| 净利润同比 | 35.3% | -19.3% |
| 每股收益（稀释后） | $0.48 | $1.72 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COLLPLPC
| Q4 25 | $205.4M | $173.1M | ||
| Q3 25 | $209.4M | $178.1M | ||
| Q2 25 | $188.0M | $169.6M | ||
| Q1 25 | $177.8M | $148.5M | ||
| Q4 24 | $181.9M | $167.1M | ||
| Q3 24 | $159.3M | $147.0M | ||
| Q2 24 | $145.3M | $138.7M | ||
| Q1 24 | $144.9M | $140.9M |
净利润COLLPLPC
| Q4 25 | $17.0M | $8.4M | ||
| Q3 25 | $31.5M | $2.6M | ||
| Q2 25 | $12.0M | $12.7M | ||
| Q1 25 | $2.4M | $11.5M | ||
| Q4 24 | $12.5M | $10.5M | ||
| Q3 24 | $9.3M | $7.7M | ||
| Q2 24 | $19.6M | $9.4M | ||
| Q1 24 | $27.7M | $9.6M |
毛利率COLLPLPC
| Q4 25 | 62.5% | 29.8% | ||
| Q3 25 | 61.7% | 29.7% | ||
| Q2 25 | 57.7% | 32.7% | ||
| Q1 25 | 54.8% | 32.8% | ||
| Q4 24 | 54.0% | 33.3% | ||
| Q3 24 | 60.8% | 31.1% | ||
| Q2 24 | 62.5% | 31.9% | ||
| Q1 24 | 63.1% | 31.3% |
营业利润率COLLPLPC
| Q4 25 | 29.6% | 6.8% | ||
| Q3 25 | 29.7% | 7.4% | ||
| Q2 25 | 18.7% | 10.1% | ||
| Q1 25 | 12.2% | 8.8% | ||
| Q4 24 | 20.9% | 10.5% | ||
| Q3 24 | 21.9% | 7.1% | ||
| Q2 24 | 32.7% | 8.1% | ||
| Q1 24 | 34.1% | 8.2% |
净利率COLLPLPC
| Q4 25 | 8.3% | 4.9% | ||
| Q3 25 | 15.0% | 1.5% | ||
| Q2 25 | 6.4% | 7.5% | ||
| Q1 25 | 1.4% | 7.8% | ||
| Q4 24 | 6.9% | 6.3% | ||
| Q3 24 | 5.9% | 5.2% | ||
| Q2 24 | 13.5% | 6.8% | ||
| Q1 24 | 19.1% | 6.8% |
每股收益（稀释后）COLLPLPC
| Q4 25 | $0.48 | $1.72 | ||
| Q3 25 | $0.84 | $0.53 | ||
| Q2 25 | $0.34 | $2.56 | ||
| Q1 25 | $0.07 | $2.33 | ||
| Q4 24 | $0.36 | $2.13 | ||
| Q3 24 | $0.27 | $1.54 | ||
| Q2 24 | $0.52 | $1.89 | ||
| Q1 24 | $0.71 | $1.94 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $386.7M | — |
| 总债务越低越好 | — | $38.3M |
| 股东权益账面价值 | $301.7M | $475.5M |
| 总资产 | $1.7B | $653.6M |
| 负债/权益比越低杠杆越低 | — | 0.08× |
8季度趋势，按日历期对齐
现金及短期投资COLLPLPC
| Q4 25 | $386.7M | — | ||
| Q3 25 | $285.9M | — | ||
| Q2 25 | $222.2M | — | ||
| Q1 25 | $197.8M | — | ||
| Q4 24 | $162.8M | — | ||
| Q3 24 | $120.0M | — | ||
| Q2 24 | $271.6M | — | ||
| Q1 24 | $318.0M | — |
总债务COLLPLPC
| Q4 25 | — | $38.3M | ||
| Q3 25 | — | $36.0M | ||
| Q2 25 | — | $31.8M | ||
| Q1 25 | — | $29.1M | ||
| Q4 24 | — | $20.8M | ||
| Q3 24 | — | $27.2M | ||
| Q2 24 | — | $31.6M | ||
| Q1 24 | — | $55.0M |
股东权益COLLPLPC
| Q4 25 | $301.7M | $475.5M | ||
| Q3 25 | $274.8M | $466.3M | ||
| Q2 25 | $232.2M | $460.7M | ||
| Q1 25 | $234.4M | $435.8M | ||
| Q4 24 | $228.8M | $422.3M | ||
| Q3 24 | $234.3M | $429.0M | ||
| Q2 24 | $216.6M | $416.2M | ||
| Q1 24 | $222.2M | $413.4M |
总资产COLLPLPC
| Q4 25 | $1.7B | $653.6M | ||
| Q3 25 | $1.6B | $644.6M | ||
| Q2 25 | $1.6B | $631.5M | ||
| Q1 25 | $1.6B | $592.5M | ||
| Q4 24 | $1.7B | $573.9M | ||
| Q3 24 | $1.6B | $592.0M | ||
| Q2 24 | $1.1B | $572.6M | ||
| Q1 24 | $1.1B | $586.1M |
负债/权益比COLLPLPC
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.08× | ||
| Q2 25 | — | 0.07× | ||
| Q1 25 | — | 0.07× | ||
| Q4 24 | — | 0.05× | ||
| Q3 24 | — | 0.06× | ||
| Q2 24 | — | 0.08× | ||
| Q1 24 | — | 0.13× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $123.0M | $21.9M |
| 自由现金流经营现金流 - 资本支出 | $122.4M | $11.8M |
| 自由现金流率自由现金流/营收 | 59.6% | 6.8% |
| 资本支出强度资本支出/营收 | 0.3% | 5.9% |
| 现金转化率经营现金流/净利润 | 7.25× | 2.60× |
| 过去12个月自由现金流最近4个季度 | $327.6M | $33.3M |
8季度趋势，按日历期对齐
经营现金流COLLPLPC
| Q4 25 | $123.0M | $21.9M | ||
| Q3 25 | $78.4M | $18.9M | ||
| Q2 25 | $72.4M | $26.9M | ||
| Q1 25 | $55.4M | $5.7M | ||
| Q4 24 | $84.6M | $24.1M | ||
| Q3 24 | $-9.0M | $9.4M | ||
| Q2 24 | $67.4M | $28.3M | ||
| Q1 24 | $61.9M | $5.8M |
自由现金流COLLPLPC
| Q4 25 | $122.4M | $11.8M | ||
| Q3 25 | $78.3M | $8.3M | ||
| Q2 25 | $72.4M | $18.6M | ||
| Q1 25 | $54.6M | $-5.3M | ||
| Q4 24 | $84.1M | $20.6M | ||
| Q3 24 | $-9.2M | $5.8M | ||
| Q2 24 | $67.1M | $24.6M | ||
| Q1 24 | $61.4M | $1.8M |
自由现金流率COLLPLPC
| Q4 25 | 59.6% | 6.8% | ||
| Q3 25 | 37.4% | 4.7% | ||
| Q2 25 | 38.5% | 10.9% | ||
| Q1 25 | 30.7% | -3.6% | ||
| Q4 24 | 46.2% | 12.3% | ||
| Q3 24 | -5.8% | 3.9% | ||
| Q2 24 | 46.2% | 17.7% | ||
| Q1 24 | 42.3% | 1.3% |
资本支出强度COLLPLPC
| Q4 25 | 0.3% | 5.9% | ||
| Q3 25 | 0.1% | 6.0% | ||
| Q2 25 | 0.0% | 4.9% | ||
| Q1 25 | 0.4% | 7.4% | ||
| Q4 24 | 0.3% | 2.1% | ||
| Q3 24 | 0.2% | 2.4% | ||
| Q2 24 | 0.2% | 2.7% | ||
| Q1 24 | 0.4% | 2.8% |
现金转化率COLLPLPC
| Q4 25 | 7.25× | 2.60× | ||
| Q3 25 | 2.49× | 7.21× | ||
| Q2 25 | 6.05× | 2.12× | ||
| Q1 25 | 22.92× | 0.49× | ||
| Q4 24 | 6.75× | 2.30× | ||
| Q3 24 | -0.96× | 1.22× | ||
| Q2 24 | 3.44× | 3.02× | ||
| Q1 24 | 2.23× | 0.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
